Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
---|---|
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-Cov-2 variants | FDA for emergency use authorization |
Moderna COVID-19 vaccine: Fact sheet for recipients and caregivers.
11Centers for Disease Control and Prevention | FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine |
---|---|
Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
When vaccine is limited, who should get vaccinated first? Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U.
6